Shun Lu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 66

Top Topics

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Therapeutic advances in medical oncology

Signal transduction and targeted therapy

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Qianming Bai, Xiaohua Shi, Xiao-Yan Zhou, Zhiyong Liang, Shun Lu, Yilong Wu
Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer. Therapeutic advances in medical oncology 16 (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Myung-Ju Ahn, Kentaro Tanaka, Luis G Paz-Ares, Robin Cornelissen, Nicolas Girard, Elvire Pons-Tostivint, David Vicente Baz, Shunichi Sugawara, Manuel Cobo, Maurice Pérol, Céline Mascaux, Elena V Poddubskaya, Satoru Kitazono, Hidetoshi Hayashi, Min Hee Hong, Enriqueta Felip Font, Richard Hall, Oscar Juan Vidal, Daniel Brungs, Shun Lu, Marina-Chiara Garassino, Michael J Chargualaf, Yong Zhang, Paul Howarth, Deise Uema, Aaron E Lisberg, Jacob M Sands, null null
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
James Chih-Hsin Yang, Dae Ho Lee, Jong-Seok Lee, Yun Fan, Filippo de Marinis, Eiji Iwama, Takako Inoue, Jerónimo Rafael Rodríguez-Cid, Li Zhang, Cheng-Ta Yang, Emmanuel de la Mora Jimenez, Jianying Zhou, Maurice Pérol, Ki Hyeong Lee, David Vicente, Eiki Ichihara, Gregory J Riely, Yiwen Luo, Diana Chirovsky, M Catherine Pietanza, Niyati Bhagwati, Shun Lu
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR -Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Zhuo Chen, Wenxiang Ji, Wenxin Feng, Jingchuan Cui, Yuchen Wang, Fan Li, Jiachen Chen, Ziheng Guo, Liliang Xia, Xiaokuan Zhu, Xiaomin Niu, Yanshuang Zhang, Ziming Li, Alice Sze Tsai Wong, Shun Lu, Wei-Liang Xia
PTPRT loss enhances anti-PD-1 therapy efficacy by regulation of STING pathway in non-small cell lung cancer. Science translational medicine 16 (763) (2024)
Ziming Li, Zhengbo Song, Wei Hong, Nong Yang, Yongsheng Wang, Hong Jian, Zibin Liang, Sheng Hu, Min Peng, Yan Yu, Yan Wang, Zicong Jiao, Kaijing Zhao, Ke Song, You Li, Wei Shi, Shun Lu
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study. Signal transduction and targeted therapy 9 (1) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ziming Li, Zhengbo Song, Wei Hong, Nong Yang, Yongsheng Wang, Hong Jian, Zibin Liang, Sheng Hu, Min Peng, Yan Yu, Yan Wang, Zicong Jiao, Kaijing Zhao, Ke Song, You Li, Wei Shi, Shun Lu
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study. Signal transduction and targeted therapy 9 (1) (2024)
Huayan Huang, Xiaokuan Zhu, Yongfeng Yu, Ziming Li, Yi Yang, Liliang Xia, Shun Lu
EGFR mutations induce the suppression of CD8 + T cell and anti-PD-1 resistance via ERK1/2-p90RSK-TGF-β axis in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Huayan Huang, Xiaokuan Zhu, Yongfeng Yu, Ziming Li, Yi Yang, Liliang Xia, Shun Lu
EGFR mutations induce the suppression of CD8 + T cell and anti-PD-1 resistance via ERK1/2-p90RSK-TGF-β axis in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Shun Lu, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhi Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lu, Yanping Hu, Liyan Jiang, Qiming Wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wancheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Jie Weng, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Hongying Wei, Jiawei Wei, Zheyu Zhang, Qiong Wu
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS). Cancer communications (London, England) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Qianming Bai, Xiaohua Shi, Xiao-Yan Zhou, Zhiyong Liang, Shun Lu, Yilong Wu
Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer. Therapeutic advances in medical oncology 16 (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Ziming Li, Zhengbo Song, Wei Hong, Nong Yang, Yongsheng Wang, Hong Jian, Zibin Liang, Sheng Hu, Min Peng, Yan Yu, Yan Wang, Zicong Jiao, Kaijing Zhao, Ke Song, You Li, Wei Shi, Shun Lu
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study. Signal transduction and targeted therapy 9 (1) (2024)
Yongfeng Yu, Wen Dong, Yanxia Shi, Rong Wu, Qitao Yu, Feng Ye, Chengzhi Zhou, Xiaorong Dong, Xingya Li, Yongsheng Li, Zhen Li, Lin Wu, Yueyin Pan, Hong Shen, Dehua Wu, Zhongyuan Xu, Jinsheng Wu, Nong Xu, Yanru Qin, Aimin Zang, Jingdong Zhang, Jianya Zhou, Xiaotao Zhang, Yanqiu Zhao, Fugen Li, Huizhen Wang, Qi Liu, Zhenyong Han, Jin Li, Shun Lu
A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib. Therapeutic advances in medical oncology 16 (2024)
Ziming Li, Zhengbo Song, Wei Hong, Nong Yang, Yongsheng Wang, Hong Jian, Zibin Liang, Sheng Hu, Min Peng, Yan Yu, Yan Wang, Zicong Jiao, Kaijing Zhao, Ke Song, You Li, Wei Shi, Shun Lu
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study. Signal transduction and targeted therapy 9 (1) (2024)
Shengnan Chen, Tao Hu, Jikai Zhao, Qian Zhu, Jin Wang, Zhan Huang, Chan Xiang, Ruiying Zhao, Changbin Zhu, Shun Lu, Yuchen Han
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance. NPJ precision oncology 8 (1) (2024)
Yongfeng Yu, Wen Dong, Yanxia Shi, Rong Wu, Qitao Yu, Feng Ye, Chengzhi Zhou, Xiaorong Dong, Xingya Li, Yongsheng Li, Zhen Li, Lin Wu, Yueyin Pan, Hong Shen, Dehua Wu, Zhongyuan Xu, Jinsheng Wu, Nong Xu, Yanru Qin, Aimin Zang, Jingdong Zhang, Jianya Zhou, Xiaotao Zhang, Yanqiu Zhao, Fugen Li, Huizhen Wang, Qi Liu, Zhenyong Han, Jin Li, Shun Lu
A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib. Therapeutic advances in medical oncology 16 (2024)
Huayan Huang, Xiaokuan Zhu, Yongfeng Yu, Ziming Li, Yi Yang, Liliang Xia, Shun Lu
EGFR mutations induce the suppression of CD8 + T cell and anti-PD-1 resistance via ERK1/2-p90RSK-TGF-β axis in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Shengnan Chen, Tao Hu, Jikai Zhao, Qian Zhu, Jin Wang, Zhan Huang, Chan Xiang, Ruiying Zhao, Changbin Zhu, Shun Lu, Yuchen Han
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance. NPJ precision oncology 8 (1) (2024)
Shengnan Chen, Tao Hu, Jikai Zhao, Qian Zhu, Jin Wang, Zhan Huang, Chan Xiang, Ruiying Zhao, Changbin Zhu, Shun Lu, Yuchen Han
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance. NPJ precision oncology 8 (1) (2024)
Jing Zhang, Sun Min Lim, Mi Ra Yu, Cheng Chen, Jia Wang, Wenqian Wang, Haopeng Rui, Jingtao Lu, Shun Lu, Tony S K Mok, Zhi Jian Chen, Byoung Chul Cho
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities. Cancer discovery (2024)
Wendi Xuzhang, Huayan Huang, Yongfeng Yu, Lan Shen, Ziming Li, Shun Lu
Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC. Therapeutic advances in medical oncology 15 (2023)
Ziming Li, Shun Lu
Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (6) (2023)
Shun Lu, Hongming Pan, Lin Wu, Yu Yao, Jianxing He, Yan Wang, Xiuwen Wang, Yong Fang, Zhen Zhou, Xicheng Wang, Xiuyu Cai, Yan Yu, Zhiyong Ma, Xuhong Min, Zhixiong Yang, Lejie Cao, Huaping Yang, Yongqian Shu, Wu Zhuang, Shundong Cang, Jian Fang, Kai Li, Zhuang Yu, Jiuwei Cui, Yang Zhang, Man Li, Xinxuan Wen, Jie Zhang, Weidong Li, Jianhua Shi, Xingxiang Xu, Diansheng Zhong, Tao Wang, Jiajia Zhu
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial. Signal transduction and targeted therapy 8 (1) (2023)
Ying Cheng, Dingzhi Huang, Jianying Zhou, Chengzhi Zhou, Yuping Sun, Lin Wu, Ye Guo, Shao Jingxin, Wanli Zhang, Shun Lu
Intracranial Activity of Selpercatinib in Chinese Patients With Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial. JCO precision oncology 7 (2023)
Zhouwenli Meng, Xiaomin Niu, Liliang Xia, Yingying Chen, Zhen Wang, Hui Wang, Ping Ji, Wenguo Cui, Ying Wang, Shun Lu
A 3D Ex Vivo Tumor-Immune Coculture System Mimicking In Vivo Tumor Environmental Stress on CD8+ T Cells Exhaustion. Advanced biology (2023)
Wendi Xuzhang, Huayan Huang, Yongfeng Yu, Lan Shen, Ziming Li, Shun Lu
Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC. Therapeutic advances in medical oncology 15 (2023)
Edward B Garon, Shun Lu, Yasushi Goto, Pedro De Marchi, Luis G Paz-Ares, David R Spigel, Michael Thomas, James Chih-Hsin Yang, Andrea Ardizzoni, Fabrice Barlesi, Sergey V Orlov, Hiroshige Yoshioka, Giannis Mountzios, Sadhvi Khanna, Claudia Bossen, Mariana Carbini, Sabine Turri, Andrea Myers, Byoung Chul Cho
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ziming Li, Shun Lu
Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (6) (2023)
Shun Lu, Xiangqian Zheng, Yuping Sun, Dingzhi Huang, Lin Wu, Qinghai Ji, Chengzhi Zhou, Jianying Zhou, Ye Guo, Minghua Ge, Ding Ding, Jingxin Shao, Wanli Zhang, Ming Gao, Ying Cheng
Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer, and RET -mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial. Therapeutic advances in medical oncology 15 (2023)
Li Zhang, Yongsheng Wang, Lizhu Lin, Yongfeng Yu, Shun Lu
Chinese multidisciplinary expert consensus on the management of adverse drug reactions associated with savolitinib. Therapeutic advances in medical oncology 15 (2023)
Chong-Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia, Jian-Ying Zhou, Dong Wan Kim, Ross Andrew Soo, Ying Cheng, Shun Lu, Sang Won Shin, James Chih-Hsin Yang, Yiping Zhang, Jun Zhao, Karin Berghoff, Rolf Bruns, Andreas Johne, Yi-Long Wu
Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yirui Cheng, Xin Lu, Fan Li, Zhuo Chen, Yanshuang Zhang, Qing Han, Qingyu Zeng, Tingyu Wu, Ziming Li, Shun Lu, Cecilia Williams, Wei-Liang Xia
NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation. Protein & cell 14 (2) (2023)
Ziming Li, Shun Lu
Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Shun Lu, Hongming Pan, Lin Wu, Yu Yao, Jianxing He, Yan Wang, Xiuwen Wang, Yong Fang, Zhen Zhou, Xicheng Wang, Xiuyu Cai, Yan Yu, Zhiyong Ma, Xuhong Min, Zhixiong Yang, Lejie Cao, Huaping Yang, Yongqian Shu, Wu Zhuang, Shundong Cang, Jian Fang, Kai Li, Zhuang Yu, Jiuwei Cui, Yang Zhang, Man Li, Xinxuan Wen, Jie Zhang, Weidong Li, Jianhua Shi, Xingxiang Xu, Diansheng Zhong, Tao Wang, Jiajia Zhu
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial. Signal transduction and targeted therapy 8 (1) (2023)
Charles M Rudin, Stephen V Liu, Ross Andrew Soo, Shun Lu, Min Hee Hong, Jong-Seok Lee, Maciej Bryl, Daphne W Dumoulin, Achim Rittmeyer, Chao-Hua Chiu, Ozgur Ozyilkan, Melissa Lynne Johnson, Alejandro Navarro, Silvia Novello, Yuichi Ozawa, Sammi Hiu Tam, Namrata S Patil, Xiaohui Wen, Meilin Huang, Tien Hoang, Raymond Meng, Martin Reck
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Roy S Herbst, Yi-Long Wu, Thomas John, Christian Grohe, Margarita Majem, Jie Wang, Terufumi Kato, Jonathan Wade Goldman, Konstantin Laktionov, Sang-We Kim, Chong-Jen Yu, Huu Vinh Vu, Shun Lu, Kye Young Lee, Guzel Mukhametshina, Charuwan Akewanlop, Filippo de Marinis, Laura Bonanno, Manuel Dómine, Frances A Shepherd, Damien Urban, Xiangning Huang, Ana Bolanos, Marta Stachowiak, Masahiro Tsuboi
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, Ross Andrew Soo, Thanyanan Reungwetwattana, James Chih-Hsin Yang, Irfan Cicin, Dong Wan Kim, Yi-Long Wu, Shun Lu, Ki Hyeong Lee, Yong-Kek Pang, Anastasia Zimina, Chin Heng Fong, Elena Poddubskaya, Ahmet Sezer, Soon Hin How, Pongwut Danchaivijitr, YuKyung Kim, Yeji Lim, Taewon An, Hana Lee, Hae Mi Byun, Bojan Zarić
Lazertinib Versus Gefitinib as First-line Treatment in Patients With EGFR -mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Oluwadamilola T Oladeru, Samantha A Dunn, Jian Li, Charlotte E Coles, Chikako Yamauchi, Jee Suk Chang, Hung Chun Skye Cheng, Orit Kaidar Person, Icro Meattini, Duvern Ramiah, Anna M Kirby, Tarek Hijal, Gustavo Nader Marta, Philip Poortmans, Josep Isern-Verdum, Yvonne Zissiadis, Birgitte Vrou Offersen, Tamer Refaat, Khaled Elsayad, Hussam Hijazi, Natalia Dengina, Yazid Belkacemi, Feng Deng Luo, Shun Lu, Colleen Griffin, Maya Collins, Phoebe Ryan, Dalia Larios, Laura E Warren, Rinaa S Punglia, Julia S Wong, Daphna Y Spiegel, Reshma Jagsi, Alphonse G Taghian, Jennifer R Bellon, Alice Y Ho
Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic. JCO global oncology 9 (2023)
Zhouwenli Meng, Xiaomin Niu, Liliang Xia, Yingying Chen, Zhen Wang, Hui Wang, Ping Ji, Wenguo Cui, Ying Wang, Shun Lu
A 3D Ex Vivo Tumor-Immune Coculture System Mimicking In Vivo Tumor Environmental Stress on CD8+ T Cells Exhaustion. Advanced biology (2023)
Shun Lu, Hongming Pan, Lin Wu, Yu Yao, Jianxing He, Yan Wang, Xiuwen Wang, Yong Fang, Zhen Zhou, Xicheng Wang, Xiuyu Cai, Yan Yu, Zhiyong Ma, Xuhong Min, Zhixiong Yang, Lejie Cao, Huaping Yang, Yongqian Shu, Wu Zhuang, Shundong Cang, Jian Fang, Kai Li, Zhuang Yu, Jiuwei Cui, Yang Zhang, Man Li, Xinxuan Wen, Jie Zhang, Weidong Li, Jianhua Shi, Xingxiang Xu, Diansheng Zhong, Tao Wang, Jiajia Zhu
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial. Signal transduction and targeted therapy 8 (1) (2023)
Shun Lu, Jian Fang, Ziping Wang, Yun Fan, Yunpeng Liu, Jian-Xing He, Jian-Ying Zhou, Jie Hu, Jinjing Xia, Wenxin Liu, Jane Shi, Jing Yi, Lejie Cao
Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer. Cancer medicine (2022)
Yongfeng Yu, Yongxin Ren, Jian Fang, Lejie Cao, Zongan Liang, Qisen Guo, Sen Han, Zimei Ji, Ye Wang, Yulan Sun, Yuan Chen, Xingya Li, Hua Xu, Jianying Zhou, Liyan Jiang, Ying Cheng, Zhigang Han, Jianhua Shi, Gongyan Chen, Rui Ma, Yun Fan, Sanyuan Sun, Longxian Jiao, Xiaoyun Jia, Linfang Wang, Puhan Lu, Qian Xu, Xian Luo, Weiguo Su, Shun Lu
Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. Therapeutic advances in medical oncology 14 (2022)
Shun Lu, Ying Cheng, Jianying Zhou, Mengzhao Wang, Jun Zhao, Baocheng Wang, Gongyan Chen, Jifeng Feng, Zhiyong Ma, Lin Wu, Chang-Li Wang, Kewei Ma, Shucai Zhang, Jun Liang, Yong Song, Jie Wang, Yi-Long Wu, Ang Li, Yizhi Huang, Jianhua Chang
An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870). Therapeutic advances in medical oncology 14 (2022)
Yuting Wang, Xiaomin Niu, Yirui Cheng, Yanshuang Zhang, Liliang Xia, Weiliang Xia, Shun Lu
Exosomal PD-L1 predicts response with immunotherapy in NSCLC patients. Clinical and experimental immunology 208 (3) (2022)
Lei Zhang, Yijiao Qian, Jinnan Li, Chenwei Cui, Lu Chen, Shuli Qu, Shun Lu
Indirect comparison of sintilimab and other PD-L1 inhibitors for first-line treatment of non-squamous non-small-cell lung cancer. Future oncology (London, England) 18 (15) (2022)
Xiaokuan Zhu, Yao Lu, Shun Lu
Landscape of Savolitinib Development for the Treatment of Non-Small Cell Lung Cancer with MET Alteration-A Narrative Review. Cancers 14 (24) (2022)
Shun Lu, Ying Cheng, Dingzhi Huang, Yuping Sun, Lin Wu, Chengzhi Zhou, Ye Guo, Jingxin Shao, Wanli Zhang, Jianying Zhou
Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321). Therapeutic advances in medical oncology 14 (2022)
Linping Gu, Huayan Huang, Zhangwendi Xu, Xiaomin Niu, Ziming Li, Liliang Xia, Yongfeng Yu, Shun Lu
Landscape and Predictive Significance of the Structural Classification of EGFR Mutations in Chinese NSCLCs: A Real-World Study. Journal of clinical medicine 12 (1) (2022)
Linping Gu, Huayan Huang, Zhangwendi Xu, Xiaomin Niu, Ziming Li, Liliang Xia, Yongfeng Yu, Shun Lu
Landscape and Predictive Significance of the Structural Classification of EGFR Mutations in Chinese NSCLCs: A Real-World Study. Journal of clinical medicine 12 (1) (2022)
Xinghao Ai, Yongfeng Yu, Jun Zhao, Wang Sheng, Jing Bai, Zaiwen Fan, Xuemei Liu, Wenxiang Ji, Rongrong Chen, Shun Lu
Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting. Therapeutic advances in medical oncology 14 (2022)
Xiaokuan Zhu, Yao Lu, Shun Lu
Landscape of Savolitinib Development for the Treatment of Non-Small Cell Lung Cancer with MET Alteration-A Narrative Review. Cancers 14 (24) (2022)
Linping Gu, Huayan Huang, Zhangwendi Xu, Xiaomin Niu, Ziming Li, Liliang Xia, Yongfeng Yu, Shun Lu
Landscape and Predictive Significance of the Structural Classification of EGFR Mutations in Chinese NSCLCs: A Real-World Study. Journal of clinical medicine 12 (1) (2022)
Shun Lu, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhi Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lu, Yanping Hu, Liyan Jiang, Qi-Ming Wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wancheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Weng Jie, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Changan Sun, Hongying Wei, Chuan Li, Siraj M Ali, Vincent A Miller, Qiong Wu
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Hui Wang, Liliang Xia, Cheng-Cheng Yao, Hui Dong, Yi Yang, Chong Li, Wen-Xiang Ji, Rui-Ming Sun, Huang-Qi Duan, Wenli Mengzhou, Wei-Min Xia, Shu-Jun Wang, Ping Ji, Ziming Li, Lei Jiao, Ying Wang, Shun Lu
NLRP4 negatively regulates type I interferon response and influences the outcome in anti-programmed cell death protein (PD)-1/PD-ligand 1 therapy. Cancer science 113 (3) (2022)
Yongfeng Yu, Fanfan Zhu, Wenxin Zhang, Shun Lu
Comparison of Efficacy and Safety of Brigatinib in First-Line Treatments for Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Systematic Review and Indirect Treatment Comparison. Journal of clinical medicine 11 (11) (2022)
Yingjia Sun, Ziming Li, Hong Jian, Liliang Xia, Shun Lu
Impact of KRAS Mutation Subtypes and Co-Occurring Mutations on Response and Outcome in Advanced NSCLC Patients following First-Line Treatment. Journal of clinical medicine 11 (14) (2022)
Xuejing Chen, Kun Li, Zichen Liu, Fei Gai, Guanshan Zhu, Shun Lu, Nan-Ying Che
Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC. Cancer medicine 10 (7) (2021)
Shun Lu, Jin-Yuan Shih, Tae-Won Jang, Chong-Kin Liam, Yongfeng Yu
Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence. Advances in therapy 38 (5) (2021)
Lan Shen, Tan Qiang, Ziming Li, Ding Ding, Yongfeng Yu, Shun Lu
First-line crizotinib versus platinum-pemetrexed chemotherapy in patients with advanced ROS1-rearranged non-small-cell lung cancer. Cancer medicine 9 (10) (2020)
Zhen Zhou, Lei Zhu, Xiaomin Niu, Shengping Shen, Yi Zhao, Jie Zhang, Junyi Ye, Han Han-Zhang, Junjun Liu, Chenglin Liu, Shun Lu
Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma. Thoracic cancer 10 (4) (2019)